Analysts at StockNews.com initiated coverage on shares of Ekso Bionics (NASDAQ:EKSO – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock.
Several other research firms have also weighed in on EKSO. Lake Street Capital lowered their target price on shares of Ekso Bionics from $2.50 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th. HC Wainwright reaffirmed a “buy” rating and set a $9.00 price objective on shares of Ekso Bionics in a research report on Tuesday, January 14th.
Read Our Latest Stock Analysis on EKSO
Ekso Bionics Stock Performance
Ekso Bionics (NASDAQ:EKSO – Get Free Report) last released its earnings results on Monday, October 28th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02). Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. The firm had revenue of $4.13 million for the quarter, compared to the consensus estimate of $6.00 million. During the same period in the prior year, the business earned ($0.24) EPS. Equities analysts anticipate that Ekso Bionics will post -0.48 earnings per share for the current fiscal year.
Ekso Bionics Company Profile
Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
Featured Stories
- Five stocks we like better than Ekso Bionics
- What is a Death Cross in Stocks?
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- How to Use the MarketBeat Stock Screener
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What Are Some of the Best Large-Cap Stocks to Buy?
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.